Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
about
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic painThe pathogenesis of lyme neuroborreliosis: from infection to inflammationDecreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed indiHuman Coinfection with Borrelia burgdorferi and Babesia microti in the United StatesRegulated Production of CXCL13 within the Central Nervous System.Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans.Increased interleukin-17 in peripheral blood and cerebrospinal fluid of neurosyphilis patientsBorrelia infection and risk of non-Hodgkin lymphomaDoxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study.An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi.Innate immunity networks during infection with Borrelia burgdorferi.Resolution of chronic hepatitis C following parasitosis.Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid.Early cytokine release in response to live Borrelia burgdorferi Sensu Lato Spirochetes is largely complement independent.Adaptive and innate immune responsiveness to Borrelia burgdorferi sensu lato in exposed asymptomatic children and children with previous clinical Lyme borreliosis.Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.Borrelia burgdorferi induces a type I interferon response during early stages of disseminated infection in mice.Lyme disease: point/counterpoint.A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi.Targeting CXCL13 During NeuroinflammationMycosis fungoides: is it a Borrelia burgdorferi-associated disease?Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.Susceptibility to Ticks and Lyme Disease Spirochetes Is Not Affected in Mice Coinfected with Nematodes.Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi.The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root gangliaCan ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.Prevention of lyme disease: promising research or sisyphean task?Difficulties of interpreting Borrelia serology in patients with uveitis.Th1 and Th17 but no Th2-related cytokine spectrum in the cerebrospinal fluid of children with Borrelia-related facial nerve palsy.Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.Lyme borreliosis reinfection: might it be explained by a gender difference in immune response?Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes.Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis.Treatment of Lyme neuroborreliosis with plasmapheresis.Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report.Propensity to excessive proinflammatory response in chronic Lyme borreliosis
P2860
Q21284848-8B231690-7809-4816-95C4-DDE61AB74C8DQ24670918-CFBA9106-4DAB-49D2-A794-C1C41A9BEFEEQ24683324-3C273BCF-49C0-4026-9D01-EADE4F523138Q26772263-91213802-C53C-4CD1-89BA-BD10B0DEAF9CQ33772300-291B64C6-F41B-4DA5-8E82-CFB73CA656ECQ33869706-CAD27DD9-106B-4EAC-83C7-64F000AC51C7Q33981683-C0A4CAF6-416D-4B60-AF87-DA63E066B867Q34275054-DAD29500-99B8-40DD-ADBD-B93161C312ACQ34372745-93DBED43-6B22-4D6D-A7E9-FC78799F95D4Q34414046-4DB27FF4-5693-4EB2-927A-A30CCB8FABA9Q34426426-DA658112-ACD8-4F16-8EA7-2832427EEF13Q34662527-5DDD26E9-3DA8-4F2B-9928-F6B0297675A3Q35025257-EA9B729E-59A0-4DD6-8CCA-A9F9326653EFQ35120442-F62B542A-D398-44CC-BA0D-421F7911FF24Q35284275-0F028B5A-F326-4290-A26E-7A1B71F7C68BQ35606433-CAD83B29-87F5-40F4-8C2D-213F04C49220Q35947260-B1AB604E-1DD0-4298-8E16-2EF5A70F8C26Q35950343-6C9E9034-C223-4C1A-A3BE-C9F398E74711Q36140640-CB19D472-FA28-4FC6-8D11-756B9F4904C0Q36156581-FEE6D5EE-8DE4-47B9-B57F-01C29BFFF647Q36551188-ABBCA0AB-EE0B-4811-9E63-E065E6D2FADEQ36614484-B9A938C7-42CE-4226-BFB7-933508EF1F7AQ36837894-9F6E64A0-EC5F-467B-AD5F-1D0CB64C4844Q36888591-6A699476-F690-4E78-B640-6B15C8389B62Q37038262-CCD36B22-8D97-4243-9A77-27FD18AE02FDQ37042125-034D4AE6-9805-456E-B057-2DB5E063562BQ37512192-03936CC5-1E36-4F20-BF68-E3DB0A37F6DDQ37679914-830932C0-1B27-4386-8C56-DDA26BFB9340Q37883972-88464577-4D2B-4BF8-9358-EB4CCC7F799CQ37902655-6D3C307F-ED12-48EA-AF92-0662AA2BBB01Q42846208-9A22D00C-1D57-4E80-A185-C57FD7E3095DQ53536611-E3DF2797-25DD-4442-8AD0-AC404525F396Q53618224-94AF9EF9-5F76-44A3-BB35-70DA14EF02DAQ53640775-C19A86CA-38EC-43E1-B368-D1D8EE7C162DQ53670760-7B82FDFB-DFFF-47E6-AD65-ACC31BB2BFA3Q54416967-EAB9B9C0-CDE0-4774-B7ED-753644B60709Q54768761-9FD39BDA-953E-40EC-9B5E-CF7ABAD7BEB2Q55100972-2B45B9A1-0CB4-4EF5-814D-8C0619F7933AQ56901558-93210DE7-2D04-4C3A-AFEA-351B8908C31D
P2860
Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@en
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@nl
type
label
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@en
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@nl
prefLabel
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@en
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@nl
P2093
P921
P356
P1476
Borrelia-specific interferon-g ...... ciation with clinical outcome.
@en
P2093
Christina Ekerfelt
Jan Ernerudh
Magnus Vrethem
Mona Widhe
Pia Forsberg
Sara Jarefors
Sven Bergstrom
P304
P356
10.1086/382893
P407
P577
2004-04-26T00:00:00Z